Home » News » Industry Specific Issues

Industry Specific Issues

Telix Pharmaceuticals solidifies Australian Biotech Success, posting net profit after years of Refundable R&D Tax Offset Recipients

September 16th, 2024

Melbourne-based Telix Pharmaceuticals has previously been one of the largest recipients of the R&D Tax incentive, and has continued its rare feat in Biotechnology; commercialising a product, and progressing to growth and profit. The company’s radiopharmaceuticals are designed to deliver focused doses of radiation with precision targeting via an injection, regardless of where the cancer or disease is in the body. In the early stages of Telix Pharmaceuticals, the company was receiving substantial refundable R&D Tax Offsets (including more than $12M […]

Read More

AusIndustry Webinar – Software Activities

March 25th, 2024

AusIndustry have announced that they will be hosting a webinar on Wednesday, 27 March, where subject matter experts will answer questions related to R&D Claims for software development, including: eligibility requirements; activity descriptions; and record keeping. Registration information is available on the AusIndustry website. Please get in touch with our office if you require assistance, would like to speak to someone about a potential claim, or check out our website for more information.

Read More

Altium Affirmed as One of Australia’s Greatest Ever Technology Companies on $9b Takeover

February 20th, 2024

Altium Ltd has origins in Hobart in the 1980’s, and sells software to help people design printed circuit boards. Following an IPO, the stock at one stage reached a low of $0.08, however, in testament to the company’s success, the company has entered a scheme of implementation agreement in February 2024 for Japan’s Renesas Electronics to acquire the company at $68.50 a share (equating to an enterprise value of around $9bn). Throughout a surge in the shareprice of tech stocks […]

Read More

AFR reports high profile ASX listed Software Company Subject to ATO Review of R&D Tax Offsets

October 18th, 2023

The AFR has reported in late September 2023, that officials from the Australian Taxation Office visited a high profile ASX listed software development company last month as part of inquiries about whether the group inappropriately claimed R&D Tax Offsets.   The article seems to suggest that the issue may relate to overclaiming of expenditure on R&D Activities conducted overseas (as opposed to whether the expenditure or activity meet the general R&D Tax Incentive criteria).   Under the R&D Tax Incentive, companies […]

Read More

Categories

Archives